EA
PAHC icon

Emerald Acquisition’s Phibro Animal Health PAHC Stock Holding History

Emerald Acquisition’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-21,641
Closed -$404K – 3035
2016
Q2 		$404K Buy
+21,641
New +$451K ﹤0.01% 2552

Other funds holding PAHC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return
VFA
Virtus Fund Advisers Hartford, Connecticut $32.1M AUM 39.5% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DIA
Denver Investment Advisors Denver, Colorado $1.89B AUM 7.9% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Emerald Acquisition's PAHC Position: Q3 2016 in Review

Emerald Acquisition sold out of Phibro Animal Health (PAHC) in Q3 2016, closing a stake of 21,641 shares — an estimated $404K sold.

Emerald Acquisition first reported a position in PAHC in Q2 2016 and held it in 1 quarter. The position peaked at $404K in Q2 2016. 122 funds tracked by Wall St. Rank hold PAHC as of Q3 2016.

  • Emerald Acquisition reported no remaining Phibro Animal Health position as of Q3 2016 after selling out during the quarter.
  • Emerald Acquisition sold 21,641 Phibro Animal Health shares in Q3 2016, an estimated $404K.
  • Emerald Acquisition first reported a position in Phibro Animal Health in Q2 2016 and held it in 1 quarter.
  • Emerald Acquisition's Phibro Animal Health position peaked at $404K in Q2 2016.
  • 122 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.